" class="no-js "lang="en-US"> David N Cade - Pharmtech Focus
Tuesday, January 31, 2023
David N Cade

David N Cade

About David N Cade

Related Story

Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate

September 29 2022

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products […]